Pesquisa | BVS Violência e Saúde

1.

A thirty-year follow-up surveillance study for neoplasia of a dutch ulcerative colitis cohort.

Stolwijk, J A M; Langers, A M J; Hardwick, J C; Veenendaal, R A; Verspaget, H W; van Hogezand, R A; Vasen, H F; van der Meulen-de Jong, A E.

ScientificWorldJournal ; 2013: 274715, 2013.

Artigo em Inglês | MEDLINE | ID: mdl-24379739

2.

Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort.

Weersma, R K; Stokkers, P C F; van Bodegraven, A A; van Hogezand, R A; Verspaget, H W; de Jong, D J; van der Woude, C J; Oldenburg, B; Linskens, R K; Festen, E A M; van der Steege, G; Hommes, D W; Crusius, J B A; Wijmenga, C; Nolte, I M; Dijkstra, G.

Gut ; 58(3): 388-95, 2009 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-18824555

3.

The effect of anti-tumour necrosis factor alpha treatment on the antibody response to influenza vaccination.

Gelinck, L B S; van der Bijl, A E; Beyer, W E P; Visser, L G; Huizinga, T W J; van Hogezand, R A; Rimmelzwaan, G F; Kroon, F P.

Ann Rheum Dis ; 67(5): 713-6, 2008 May.

Artigo em Inglês | MEDLINE | ID: mdl-17965123

4.

Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.

Meijer, M J W; Mieremet-Ooms, M A C; van der Zon, A M; van Duijn, W; van Hogezand, R A; Sier, C F M; Hommes, D W; Lamers, C B H W; Verspaget, H W.

Dig Liver Dis ; 39(8): 733-9, 2007 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-17602907

5.

Guidelines for treatment with infliximab for Crohn's disease.

Hommes, D W; Oldenburg, B; van Bodegraven, A A; van Hogezand, R A; de Jong, D J; Romberg-Camps, M J L; van der Woude, J; Dijkstra, G.

Neth J Med ; 64(7): 219-29, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-16929083

6.

Skeletal morbidity in inflammatory bowel disease.

van Hogezand, R A; Hamdy, N A T.

Scand J Gastroenterol Suppl ; (243): 59-64, 2006.

Artigo em Inglês | MEDLINE | ID: mdl-16782623

7.

Expression of matrix metalloproteinases-2 and -9 in intestinal tissue of patients with inflammatory bowel diseases.

Gao, Q; Meijer, M J W; Kubben, F J G M; Sier, C F M; Kruidenier, L; van Duijn, W; van den Berg, M; van Hogezand, R A; Lamers, C B H W; Verspaget, H W.

Dig Liver Dis ; 37(8): 584-92, 2005 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-15869913

8.

The future role of anti-tumour necrosis factor-alpha products in the treatment of Crohn's disease.

van Hogezand, R A; Verspaget, H W.

Drugs ; 56(3): 299-305, 1998 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-9777308

9.

Proximal Crohn's disease: review of the clinicopathologic features and therapy.

van Hogezand, R A; Witte, A M; Veenendaal, R A; Wagtmans, M J; Lamers, C B.

Inflamm Bowel Dis ; 7(4): 328-37, 2001 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-11720325

10.

Budesonide and prednisolone suppress peripheral blood natural killer cells in Crohn's disease.

Van Ierssel, A J; Van der Sluys Veer, A; Verspaget, H W; Griffioen, G; Van Hogezand, R A; Lamers, C B.

Aliment Pharmacol Ther ; 9(2): 173-8, 1995 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-7605858

11.

Suppression of intestinal mucosal natural killer cells by corticosteroids.

Van Ierssel, A J; Mieremet-Ooms, M A; Van der Zon, J M; Van Hogezand, R A; Griffioen, G; Lamers, C B; Verspaget, H W.

Aliment Pharmacol Ther ; 11(2): 347-53, 1997 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-9146774

12.

Double-blind comparison of 5-aminosalicylic acid and acetyl-5-aminosalicylic acid suppositories in patients with idiopathic proctitis.

van Hogezand, R A; van Hees, P A; van Gorp, J P; van Lier, H J; Bakker, J H; Wesseling, P; van Haelst, U J; van Tongeren, J H.

Aliment Pharmacol Ther ; 2(1): 33-40, 1988 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-2979230

13.

Effects of anti-tumour necrosis factor-alpha therapy on the quality of life in Crohn's disease.

van Balkom, B P J; Schoon, E J; Stockbrügger, R W; Wolters, F L; van Hogezand, R A; van Deventer, S J H; Oldenburg, B; van Dullemen, H M; Russel, M G V M.

Aliment Pharmacol Ther ; 16(6): 1101-7, 2002 Jun.

Artigo em Inglês | MEDLINE | ID: mdl-12030951

14.

Gastrin releasing peptide receptor expression is decreased in patients with Crohn's disease but not in ulcerative colitis.

ter Beek, W P; Muller, E S M; Van Hogezand, R A; Biemond, I; Lamers, C B H W.

J Clin Pathol ; 57(10): 1047-51, 2004 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-15452158

15.

Levels of circulating cellular fibronectin are increased in patients with rheumatoid vasculitis.

Voskuyl, A E; Emeis, J J; Hazes, J M; van Hogezand, R A; Biemond, I; Breedveld, F C.

Clin Exp Rheumatol ; 16(4): 429-34, 1998.

Artigo em Inglês | MEDLINE | ID: mdl-9706423

16.

Medical management of patients with difficult-to-treat inflammatory bowel disease.

van Hogezand, R A.

Neth J Med ; 45(2): 55-9, 1994 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-7936006

17.

Management of recurrent Crohn's disease.

van Hogezand, R A; Bemelman, W A.

Neth J Med ; 53(6): S32-8, 1998 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-9883012

18.

Selective immunomodulation in patients with inflammatory bowel disease--future therapy or reality?

van Hogezand, R A; Verspaget, H W.

Neth J Med ; 48(2): 64-7, 1996 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-8819802

19.

Assessment of inflammatory activity in Crohn's disease.

Lamers, C B; Biemond, I; van der Sluys Veer, A; van Hogezand, R A.

Neth J Med ; 45(2): 52-4, 1994 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-7936005

20.

Laparoscopic-assisted bowel resections in inflammatory bowel disease: state of the art.

Bemelman, W A; van Hogezand, R A; Meijerink, W J; Griffioen, G; Ringers, J.

Neth J Med ; 53(6): S39-46, 1998 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-9883013

BVS Violência e Saúde

Informação e Conhecimento para a Saúde

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar: